Combination treatment with rituximab and belimumab in shrinking lung syndrome in systemic lupus erythematosus

Int J Rheum Dis. 2024 Mar;27(3):e15110. doi: 10.1111/1756-185X.15110.

Authors

Adriana C Esteves¹, Beatriz Mendes¹, Helena Assunção^{2

3}, Luís S Inês^{1

4}

Affiliations

¹ Rheumatology Department, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.
² Rheumatology Department, Unidade Local de Saúde de Trás-os-Montes e Alto Douro, Vila Real, Portugal.
³ Rheumatology Department, Unidade Local de Saúde do Nordeste, Bragança, Portugal.
⁴ School of Health Sciences, Universidade da Beira Interior, Covilhã, Portugal.

PMID: 38450994
DOI: 10.1111/1756-185X.15110

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized*
Autoimmune Diseases*
Humans
Lung
Lupus Erythematosus, Systemic* / complications
Lupus Erythematosus, Systemic* / diagnosis
Lupus Erythematosus, Systemic* / drug therapy
Muscular Diseases*
Rituximab / adverse effects

Substances

belimumab
Rituximab
Antibodies, Monoclonal, Humanized